Durable Response to Crizotinib in a Patient with Pulmonary Adenocarcinoma Harboring MET Intron 14 Mutation: A Case Report
Keyword(s):
2020 ◽
Vol 49
(6)
◽
pp. 512-514
2019 ◽
Vol 37
(4)
◽
pp. 791-795
◽
Keyword(s):
1988 ◽
Vol 27
(1)
◽
pp. 63-64
◽
Keyword(s):